1. From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2018. [Elektronnyi resurs] Available from: http://www.ginasthma.org/.
2. Price D., Fletcher M., van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir. Med 2014;24:14009.
3. Buhl R., Kuna P., Peters M.J. et al. The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomized, controlled studies with comparisons to standard therapy. Respir. Res. 2012. doi.org/10.1186/1465-9921-13-59.
4. Suissa S., Ernst P., Boivin J.F. et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am. J. Respir. Crit. Care Med. 1994;149:604-610.
5. Suissa S., Ernst P., Benayoun S. et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N. Engl. J. Med. 2000;343:332-336.